Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
WMJ ; 112(2): 69-73, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23758018

RESUMO

Ensuring optimal readiness for surgery using a preoperative checklist has been shown to reduce perioperative morbidity and mortality in both elective and urgent surgeries. We recently introduced hemodynamic optimization as part of our preoperative preparedness strategy for cardiothoracic surgery. Here we describe the case of a patient with severe mitral regurgitation and suboptimal hemodynamics that was optimized preoperatively with nesiritide to reduce pulmonary hypertension. Postoperatively, the patient had an improvement of his heart failure from New York Heart Association functional class 3 to class 1. Without hemodynamic optimization the patient may have been considered too high-risk to undergo mitral valve repair. This case report illustrates the importance of a systemic approach with high-risk surgery, and the use of strategies that optimize key patient factors, including hemodynamics, prior to all elective and urgent procedures.


Assuntos
Lista de Checagem , Hemodinâmica/fisiologia , Insuficiência da Valva Mitral/cirurgia , Natriuréticos/uso terapêutico , Peptídeo Natriurético Encefálico/uso terapêutico , Cuidados Pré-Operatórios/métodos , Idoso , Humanos , Masculino , Insuficiência da Valva Mitral/diagnóstico , Insuficiência da Valva Mitral/fisiopatologia , Medição de Risco , Fatores de Risco
2.
Clin Med Res ; 5(4): 218-26, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18086906

RESUMO

Patent foramen ovale (PFO) is an anatomical variant of the interatrial septum with an overall prevalence of 27% in autopsy studies. PFOs have a potential role in causation of stroke, platypneaorthodeoxia, decompression sickness, right to left shunt and migraine headaches. Data regarding percutaneous closure of PFO in low volume tertiary care centers is lacking. Retrospective review of 14 percutaneous PFO closures done in our facility from March 2005 to August 2006 was performed for efficacy of procedure and safety. All patients received clopidogrel for a period of 3 months, and aspirin and subacute bacterial endocarditis prophylaxis for 6 months. Mean age of the study population was 54 years. Fifty percent (7 of 14) of patients experienced an atrial septal aneurysm and 14% (2 patients) exhibited a hypercoagulable state. The indication for closure in 13 patients was transient ischemic attacks or strokes, while one patient had persistent hypoxia due to a severe right to left shunt at PFO. Patients received either a CardioSEAL or Amplatzer device. Deployment rate was 100%. All patients completed a minimum of 6 months of follow-up, with a mean follow-up time of 14.9 +/- 7.6 months. No immediate or late bleeding complication occurred in any patient. One patient developed paroxysmal atrial fibrillation and one patient developed thrombotic complications at 7 months post-procedure secondary to the progression of her anal carcinoma and subsequently died. Pending the results of the four large randomized trials that are enrolling patients, percutaneous closure of PFO for cryptogenic strokes is an attractive alternative to lifelong anticoagulation with relatively few complications, even in low volume centers. There are many challenges in the management of this subset of patients, the foremost being the selection of a target patient population. Role of PFO in migraines is less clear.


Assuntos
Angioplastia Coronária com Balão/métodos , Forame Oval Patente/terapia , Seguimentos , Humanos , Estudos Retrospectivos , Resultado do Tratamento
3.
WMJ ; 104(7): 26-30, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16294596

RESUMO

PROBLEM: The Marshfield Youth (MY) Health Study was designed to identify parental and infant factors associated with childhood and adolescent overweight. METHODS: The study examined 867 children (age 5-17 years) from the Marshfield Public Schools. Heights and weights were measured by standard methods. Age- and gender-specific body mass index (BMI) percentiles and z-scores were determined. Definitions of overweight from the Centers for Disease Control and Prevention were applied. Family characteristics were self-reported by questionnaire and included parents' BMI, employment, education, smoking, physical activity; and child's daycare attendance, and television/computer use. Maternal and child medical records were reviewed. RESULTS: The MY Health cohort included 361 families. The mean +/- SD age of the children was 12.1 +/- 3.0 yrs; 511 (59%) were born in Marshfield, Wis. Of the children studied, 70% had a healthy body weight (BMI >5th and <85th percentile); 14.4% were at risk of overweight (BMI > or = 85th and <95th percentile) and 13% were overweight (BMI > or = 95th percentile). There were no differences in gender or weight status between the study cohort and all Marshfield school children (n=2782). CONCLUSIONS: Children in the MY Health Study are representative of all school-age children in Marshfield. This cohort will be studied to identify factors associated with overweight among children.


Assuntos
Nível de Saúde , Sobrepeso , Medição de Risco , Adolescente , Antropometria , Distribuição de Qui-Quadrado , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Obesidade/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Inquéritos e Questionários , Wisconsin/epidemiologia
4.
Can J Cardiol ; 21(8): 701-3, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16003453

RESUMO

Mycotic aneurysms of the coronary artery with underlying infective endocarditis are rare. The present report discusses the case of a 53-year-old woman with acute ST elevation myocardial infarction in the setting of native aortic valve endocarditis. Percutaneous transluminal coronary angioplasty was performed. Approximately four weeks after hospital admission, the patient had systemic embolization to the extremities with resulting cyanosis of the left toes. She was evaluated for replacement of the aortic valve and underwent a repeat angiogram, which demonstrated a mycotic aneurysm at the site of the angioplasty. She subsequently underwent successful excision of the aneurysm with coronary artery bypass grafting and replacement of the aortic valve with a 21 mm St Jude aortic valve prosthesis. The remaining hospital course was unremarkable.


Assuntos
Aneurisma Infectado/diagnóstico , Enterococcus , Infecções por Bactérias Gram-Positivas/complicações , Aneurisma Infectado/complicações , Aneurisma Infectado/patologia , Aneurisma Infectado/cirurgia , Valva Aórtica , Ponte de Artéria Coronária , Vasos Coronários/patologia , Diagnóstico Diferencial , Feminino , Implante de Prótese de Valva Cardíaca , Humanos , Pessoa de Meia-Idade
5.
WMJ ; 101(7): 24-33, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12426917

RESUMO

The incidence of infective endocarditis (IE) is thought to be around 4/100,000 person years in the general population, and 15/100,000 over the age of 50 years. The risk of acquiring IE is higher among patients with valvular heart disease (e.g., rheumatic valves, bicuspid aortic valves, myxomatous degeneration, etc.), congenital heart disease (e.g., coarctation, patent ductus arteriosus, ventricular septal defect, etc.), prosthetic cardiac valves, and among intravenous drug abusers. Staphylococcus aureus is one of the most common infective agents of IE, and most commonly originates from nosocomial sources, e.g., intravenous and arterial catheters, pacemaker leads, and prosthetic valves. Endocarditis caused by S aureus has a mortality rate of approximately 20% to 40%. In up to 40% of patients, IE caused by S aureus is associated with embolic complications. The risk of death increases with the development of complications. The epidemiology and microbiology of S aureus are changing rapidly, and resistance to antibiotics, especially methicillin, is becoming more widespread. In this review we will focus on the epidemiology, microbiology, and pathogenesis of S aureus IE, and also summarize the current guidelines for diagnosis, treatment, and prophylaxis of this clinical condition.


Assuntos
Antibacterianos/uso terapêutico , Endocardite Bacteriana , Antibioticoprofilaxia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/epidemiologia , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/terapia , Humanos , Incidência , Prognóstico , Recidiva , Fatores de Risco , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/epidemiologia , Infecções Estafilocócicas/terapia , Staphylococcus aureus
6.
WMJ ; 101(3): 37-9, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12109199

RESUMO

BACKGROUND: A 69-year-old man presented with a history of spiking fevers and symptoms of transient expressive aphasia and a left hemispheric cerebrovascular accident. A transthoracic echocardiogram revealed thickened mitral leaflets. A subsequent transesophageal echocardiogram demonstrated vegetations on both mitral leaflets and severe mitral regurgitation by color flow imaging. A gram-positive coccus was isolated from the blood culture of this patient. METHODS: The bacterium was identified by polymerase chain reaction (PCR) amplification of its 16S rRNA gene with the broad range eubacterial primers, FD1 and RD1, followed by sequencing of the PCR product. The obtained sequence was compared to all sequences deposited in GenBank and the ribosomal database project II. A phylogenetic tree was created to determine the relatedness of this bacterium to other bacterial species. RESULTS: The phylogenetic tree created from the 1389 bp 16S rDNA sequence indicated that the endocarditis was due to Gemella sanguinis, a member of the normal oral flora and a rare cause of bacteremia. CONCLUSION: This report describes the second case of endocarditis caused by G. sanguinis. A history of periodontal disease and tooth abscess in this patient suggests that the oropharynx was the probable origin of the Gemella bacteremia. We propose that G. sanguinis should be added to the list of Gemella species that can cause endocarditis.


Assuntos
Endocardite Bacteriana/microbiologia , Cocos Gram-Positivos/isolamento & purificação , Idoso , Antibacterianos/uso terapêutico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/cirurgia , Gentamicinas/uso terapêutico , Cocos Gram-Positivos/efeitos dos fármacos , Cocos Gram-Positivos/genética , Humanos , Masculino , Reação em Cadeia da Polimerase , RNA Ribossômico 16S/genética , Vancomicina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...